-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Maintains Buy on RxSight, Lowers Price Target to $11

Benzinga·05/07/2026 11:24:08
Listen to the news
Needham analyst David Saxon maintains RxSight (NASDAQ:RXST) with a Buy and lowers the price target from $13 to $11.